Eosinophilic leukemia is a rare entity classified under “myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions” (MLN-TK) according to the WHO and ICC criteria (20). This evidence concerns the gene TKT and lymphoid neoplasm.